摘要
乳腺癌是全球范围内女性最常见、致死人数最多的恶性肿瘤,社会负担巨大。目前,化疗仍是晚期乳腺癌最重要的治疗方式之一,其中铂类药物是乳腺癌化疗的常用药物。中国医师协会肿瘤医师分会乳腺癌学组组织相关专家,基于循证医学证据,深入探讨晚期乳腺癌中铂类药物的临床应用,针对其临床适宜阶段、方案、疗效、不良反应提出合理建议,以指导临床医师合理用药,进一步规范诊疗行为。
Breast cancer is the most common and fatal malignant tumor in women,which causes great social burden throughout the world.At present,chemotherapy is still the most important treatment manner of advanced breast cancer,and platinum drugs are one of the commonly used chemotherapeutic drugs.Based on the substantial evidence,the expert committee deeply discusses the clinical application of platinum drugs in advanced breast cancer,gives the reasonable suggestions for its clinical usage,effectiveness and adverse effects.This consensus aims to guide physicians to use drugs reasonably and standardize the diagnosis and treatment.
出处
《中华肿瘤杂志》
CAS
CSCD
北大核心
2021年第2期167-175,共9页
Chinese Journal of Oncology
基金
国家重点研发计划(2018YFC0115204)
国家自然科学基金(81672634)
首都卫生发展科研专项课题(首发2018-2-4023)
中国医学科学院临床转化与医学研究基金(12019XK320071)。
关键词
乳腺肿瘤
晚期
铂类药物
临床应用
专家共识
Breast neoplasms,advanced
Platinum
Clinical application
Expert consensus
